Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Doug Drysdale Recent news which mentions Doug Drysdale Cybin Reports Access To $101M To Sustain Deuterated Psychedelics Programs, Q2 Numbers & 2024 Goals November 15, 2023 Tickers CYBN Tags Earnings News CYBN From Benzinga Cybin Stock Down On Laying Off 15% Of Workforce As Part Of A Streamlining Clinical Alignment February 23, 2023 Tickers CYBN Tags Psychedelics CYBN News From Benzinga Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment February 01, 2023 Tickers CYBN DMT Tags Psychedelics Market News Cybin From Benzinga Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family September 27, 2022 Tickers CYBN MSSTF Tags Market News Cybin Cannabis From Benzinga Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression August 30, 2022 Tickers CYBN Tags News Cybin Inc/ General From Benzinga BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression August 17, 2022 Tickers CYBN DEA MDD Tags Legal CYBN Clinilabs From Benzinga Cybin's Psilocybin Analog CYB003 Gets FDA Clearance For Trial To Potentially Treat Major Depressive Disorder June 28, 2022 Tickers CYBN Tags Benzinga Cannabis Market News From Benzinga Cybin Closes Fiscal Year 2022, Reports Financial Results And Major Achievements June 22, 2022 Tickers CYBN Tags Management CYBN News From Benzinga Elon Musk Says Psychedelics Should Be Seriously Considered For Therapeutic Uses, Leading Chorus Of Celeb Support June 10, 2022 Tickers CYBN TWTR Tags Jim Cramer Markets Doug Drysdale From Benzinga Largest Phase-1 DMT Study In The Netherlands, A Collaboration Between Entheon & Cybin June 07, 2022 Tickers CYBE CYBN ENTBF Tags ENTBF News CYBE From Benzinga Major Depressive Disorder Could Soon Have Treatment Option Via Cybin's Psilocybin Analog May 31, 2022 Tickers CYBN Tags FDA Benzinga Market News From Benzinga Cybin's Major Depressive Disorder Treatment Trials Continue With Clinilabs Drug Development Corp April 22, 2022 Tickers CYBN Tags News CYBN General From Benzinga EXCLUSIVE: How Cybin Is Developing The Next Generation Of Psychedelics April 19, 2022 Tickers CYBN DMT PCC Tags News CYBN DMT From Benzinga A Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our Speakers April 06, 2022 Tickers AGN CYBN PTX Tags CYBN News AGN From Benzinga Cybin, MindMed, And Field Trip Health Headline PSYC's First CEO Round Table Event February 14, 2022 Tickers CYBN FTRP MMDCF PSYC Tags Cannabis Kevin O’Leary Market News From Benzinga Cybin Obtains U.S. Patent For Is Proprietary Compound Deuterated DMT Aimed At Treating Anxiety Disorders February 09, 2022 Tickers CYBN Tags News CYBN Market News From Benzinga Psychedelics Biotech Companies Mark New Milestones In Drug Development Pipelines: Field Trip, Cybin and Wesana January 11, 2022 Tickers CYBN FTRP WSNAF Tags Market News Cannabis Penny Stocks From Benzinga Why Cybin Shares Are Rising January 11, 2022 Tickers CYBN Tags why it's moving Movers CYBN From Benzinga Cybin Reports Q2 Financial Results And Latest News, Including FDA & DEA Research Approvals November 15, 2021 Tickers CYBN Tags Doug Drysdale Penny Stocks Benzinga From Benzinga Cybin Announces Positive Data Showing Effectiveness of Psilocybin To Treat Depression November 08, 2021 Tickers CYBN Tags Small Cap Biotech Psychedelics Therapy From Benzinga Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval November 08, 2021 Tickers CMPS CYBN FLHLF NMLSF Tags Small Cap Ian McDonald Cannabis From Benzinga Cybin Becomes First Psychedelics Company On The NYSE: CEO Explains Everything You Need To Know August 05, 2021 Tickers CLXPF CMPS GBNH Tags Doug Drysdale Benzinga CLXPF From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.